Electrospinning of pullulan-based orodispersible films containing sildenafil

• Published in: International journal of pharmaceutics Vol. 643; p. 123258
• Main Authors: Ravasi, Elisabetta, Melocchi, Alice, Arrigoni, Alessia, Chiappa, Arianna, Gennari, Chiara Grazia Milena, Uboldi, Marco, Bertarelli, Chiara, Zema, Lucia, Briatico Vangosa, Francesco
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 25.08.2023
• Subjects: Drug delivery; Fast-dissolving; Green pharmaceutics; Nanofibers; Natural polymer; Pediatric patients; Rheology; Fast-dissolving; A.M; Rheology; Natural polymer; E.R; Drug delivery; Pediatric patients; F.B.V; A.A; M.U; A.C; C.B; L.Z; Nanofibers; Green pharmaceutics; C.G
• ISSN: 0378-5173; 1873-3476; 1873-3476
• DOI: 10.1016/j.ijpharm.2023.123258

[Display omitted] Feasibility of electrospinning in the manufacturing of sildenafil-containing orodispersible films (ODFs) intended to enhance oxygenation and to reduce pulmonary arterial pressure in pediatric patients was evaluated. Given the targeted subjects, the simplest and safest formulation was chosen, using water as the only solvent and pullulan, a natural polymer, as the sole fiber-forming agent. A systematic characterization in terms of shear and extensional viscosity as well as surface tension of solutions containing different amounts of pullulan and sildenafil was carried out. Accordingly, electrospinning parameters enabling the continuous production, at the highest possible rate, of defect-free fibers with uniform diameter in the nanometer range were assessed. Morphology, microstructure, drug content and relevant solid state as well as ability of the resulting non-woven films to interact with aqueous fluids were evaluated. To better define the role of the fibrous nanostructure on the performance of ODFs, analogous films were produced by spin- and blade-coating and tested. Interestingly, the disintegration process of electrospun products turned out to be the fastest (i.e. occurring within few s) and compliant with Ph. Eur. and USP limits, making relevant ODFs particularly promising for increasing sildenafil bioavailability, thus lowering its dosages.